Skip to Content
Founding membership now open. Your launch price locked for 12 months, with your baseline panel included.  →
SOVRYN
Published · Peer-Reviewed · Nature Portfolio

Forecast Your Health Like the Weather.

Biometric forecasting, pioneered by our published science.

SOVRYN is founded on the peer-reviewed science of co-founder Dr. Antony Chu. His neural-network research, published in a Nature Portfolio journal, showed that the body’s own signals can do more than describe the present — they can forecast what comes next.

Even today’s best therapeutics are reactive at best: we treat after the symptom, the injury, the decline. Medicine is still living in a world before the weather forecast.

What would you do if you knew it would rain tomorrow — for your energy, your recovery, your heart?

SOVRYN is built to read your unique biologic signature and move care from monitoring to forecasting — so your protocol acts before the storm, not after it. Greater vitality. Optimized performance. Planned ahead.

The Published Study

Varghese AJ, Gatsonis AN, Agraz M, Oommen V, Parulkar A, Chu A, et al., Karniadakis GE. A multifaceted approach for obstructive sleep apnea classification from ECG signal using deep learning. npj Biological Timing and Sleep 3, 38 (2026), published August 5, 2026, open access.

doi:10.1038/s44323-026-00101-4

In Plain Language

Sleep apnea is a condition in which breathing repeatedly pauses during sleep. The study tested whether deep-learning models can detect apnea events, estimate how severe they are, and forecast them from the electrocardiogram (ECG), and whether a model can be adapted to an individual patient.

The authors evaluated their models on three datasets: PhysioNet Apnea-ECG, the OSASUD stroke-unit dataset, and data from St. Vincent’s University Hospital. KardioStatus support is acknowledged in the paper.

Why this matters to you. This study reveals the processing power behind SOVRYN. Co-founder Dr. Antony Chu and colleagues trained neural networks to read the heart’s electrical signal and forecast clinically meaningful events before they happen — personalized to the individual patient.

That same approach — continuous biometrics, interpreted by neural networks, turned into forward-looking insight — is the core of SOVRYN’s mission. Medicine today waits for the problem. SOVRYN is built to see it coming. This is the science we developed, and it is the foundation we are applying to your care.

In Plain Language

Sleep apnea is a condition in which breathing repeatedly pauses during sleep. The study tested whether deep-learning models can detect apnea events, estimate how severe they are, and forecast them from the electrocardiogram (ECG), and whether a model can be adapted to an individual patient.

The authors evaluated their models on three datasets: PhysioNet Apnea-ECG, the OSASUD stroke-unit dataset, and data from St. Vincent’s University Hospital. KardioStatus support is acknowledged in the paper.

What this study is not. It is a sleep-apnea study. It does not show how any person will respond to a peptide or GLP-1 medication, and it does not describe a SOVRYN diagnostic product. SOVRYN does not claim FDA clearance, autonomous diagnosis, or that any model predicts your results.

From Published Science to Your Care

Published Foundation

Published research

A peer-reviewed study of ECG-based deep learning for obstructive sleep apnea, co-authored by Dr. Antony Chu and acknowledging KardioStatus support.

SOVRYN Clinical Protocols

In practice today

Every protocol begins with your goal and your data. Your physician-led team sets a clear objective, establishes your baseline from your history, labs and biometrics, and reviews your progress on a fixed schedule, adjusting dose, timing and therapy as your data changes.

Each step is planned, owned and reviewed with Navy SEAL discipline: a defined mission, clear accountability, and relentless follow-through toward your goal.

The SOVRYN Approach

Closed-Loop Therapeutics.

Human in the Loop.

Closed-Loop Therapeutics. Human in the Loop.

The SOVRYN Approach

Your biometrics flow in. Neural-network analytics turn them into insight. Your physician turns insight into action — then measures the impact and refines your protocol. A continuous loop that drives your vitality and performance forward, with expert judgment at every turn.

SOVRYN Core Principles

From Biometrics to Breakthrough Performance.

  1. 01

    Measure

    Your individual biometrics, labs and history define your unique starting point.

  2. 02

    Analyze

    Your trends, interpreted through analytics built on our published neural-network science.

  3. 03

    Decide

    Elite physicians make every clinically actionable decision. Human in the loop, always.

  4. 04

    Re-assess

    Continuous review of therapeutic impact, governed by Navy SEAL discipline, until you reach your goal.

This is how SOVRYN turns potential into performance.

Take the Assessment →

Status: the published study concerns sleep apnea. Peptide-specific models are in development and are not an available prediction service. The KardioStatus connection reflects the founder’s stated vision, and SOVRYN’s application roadmap is supplied by Dr. Chu and is not established by the publication. Page version 2, October 5, 2026.